drugset / Trial / NCT04801433

Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis

NCT04801433 ↗

Completed 240 enrolled Xijing Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

A multicenter, randomized, single-blind, parallel-controlled clinical study to evaluate the efficacy and safety of boroda supramolecular active zinc in the treatment of scalp psoriasis. Main objective::Compare the efficacy of boroda supramolecular active zinc and capotetriol liniment in the treatment of scalp psoriasis Secondary objective: To observe the safety of boroda supramolecular active zinc in the treatment of subjects with scalp psoriasis

Timeline

Start
2018-11-30
Primary completion
2019-07-04
Completion
2019-11-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Capotetriol Unknown — Topical

Indications